Mitotane Therapy Monitoring

What is Mitotane Therapy Monitoring?

Mitotane therapy monitoring involves regular blood testing to track how your body responds to mitotane treatment. Mitotane is a medication used to treat adrenal cortical carcinoma, a rare cancer of the adrenal glands. The adrenal glands sit on top of your kidneys and make hormones that control stress response, blood pressure, and metabolism.

Mitotane works by destroying adrenal tissue, including both cancer cells and healthy adrenal cells. This means the drug intentionally causes adrenal insufficiency, a condition where your body cannot make enough cortisol. Cortisol is a vital hormone that helps your body handle stress, regulate blood sugar, and control inflammation.

Regular monitoring through blood tests helps your doctor find the right mitotane dose and determine if you need cortisol replacement therapy. Testing tracks cortisol levels to make sure they stay in a safe range. Too little cortisol can cause serious health problems, while the right amount keeps your body functioning properly during cancer treatment.

Cortisol, Total

Pinpoint the cause of your stress
Reveal hidden adrenal issues effortlessly
Clarify why you're feeling constantly tired

^$99

Addison's Disease Screen (Basic)

Pinpoint the cause of your fatigue
Reveal hidden adrenal issues effortlessly
Clarify unexplained weight loss or gain

^$235

Weight Loss Checkup

Tracks health factors for weight loss
Monitors essential weight-related metrics
Checks body functions affecting weight

^$252

Symptoms

Extreme fatigue and weakness
Nausea, vomiting, and loss of appetite
Dizziness or lightheadedness, especially when standing
Low blood pressure
Weight loss
Confusion or mental fog
Abdominal pain
Salt cravings
Muscle or joint pain
Darkening of skin in some areas

These symptoms reflect adrenal insufficiency caused by mitotane treatment. Some people may not notice symptoms early in treatment. However, low cortisol levels can become dangerous quickly if not caught through regular testing.

Causes and risk factors

Mitotane therapy monitoring is necessary because the medication intentionally damages adrenal tissue as part of cancer treatment. Adrenal cortical carcinoma is a rare and aggressive cancer that requires strong treatment. Mitotane destroys both cancerous and healthy adrenal cells, which stops hormone production. This creates a planned side effect called iatrogenic adrenal insufficiency, meaning the insufficiency is caused by medical treatment.

The need for monitoring increases with higher mitotane doses and longer treatment duration. Individual responses to mitotane vary widely, so some patients develop adrenal insufficiency faster than others. Factors like age, overall health, kidney function, and liver function affect how your body processes mitotane. Regular testing ensures your cortisol levels stay safe throughout treatment and helps doctors adjust both mitotane doses and hormone replacement therapy as needed.

How it's diagnosed

Mitotane therapy monitoring relies on regular cortisol blood tests to track adrenal function during treatment. Your doctor will order baseline cortisol testing before starting mitotane, then schedule repeat tests throughout your treatment course. Testing frequency depends on your mitotane dose, treatment phase, and how your body responds. Most patients need testing every few weeks initially, then monthly or quarterly once doses stabilize.

Rite Aid makes monitoring simple with testing available at over 2,000 Quest Diagnostics locations nationwide. Our flagship panel includes cortisol testing along with 200+ other biomarkers for $349 per year. You get two complete tests annually, helping you and your oncologist track treatment response. Your doctor uses cortisol results to adjust mitotane dosing and determine if you need hydrocortisone or other steroid replacement therapy.

Treatment options

Hydrocortisone or prednisone replacement to maintain adequate cortisol levels
Fludrocortisone to replace aldosterone if needed for blood pressure and salt balance
Adjusting mitotane dose based on blood levels and cortisol results
Increasing steroid doses during illness, surgery, or physical stress
Taking medications with food to reduce nausea and stomach upset
Eating adequate healthy fats, as mitotane is stored in body fat
Wearing medical alert identification noting adrenal insufficiency
Keeping emergency injectable hydrocortisone available
Regular blood testing to guide all treatment decisions
Working closely with both oncology and endocrinology specialists

Frequently asked questions

Testing frequency varies based on treatment phase and individual response. Most patients need cortisol checks every 2 to 4 weeks when starting mitotane or changing doses. Once your levels stabilize, testing may decrease to monthly or every 3 months. Your oncologist will create a monitoring schedule based on your specific situation and treatment goals.

Target cortisol levels depend on your specific treatment protocol and replacement therapy. Most doctors aim to keep morning cortisol levels above 5 to 10 micrograms per deciliter with replacement therapy. However, mitotane treatment intentionally lowers natural cortisol production. Your doctor balances cancer treatment effectiveness with maintaining safe cortisol levels through hormone replacement.

Never stop cortisol replacement without your doctor's guidance. Even if you feel well, your adrenal glands cannot produce enough cortisol during mitotane therapy. Stopping replacement suddenly can trigger an adrenal crisis, a life-threatening emergency. Your doctor will adjust doses based on blood tests and symptoms, but you will likely need replacement throughout mitotane treatment.

Severely low cortisol can cause an adrenal crisis, a medical emergency requiring immediate treatment. Symptoms include severe weakness, confusion, very low blood pressure, vomiting, and loss of consciousness. Contact your doctor immediately if you experience these symptoms. Treatment involves emergency intravenous hydrocortisone and fluids, usually in a hospital setting.

Recovery depends on treatment duration and how much adrenal tissue remains functional. Some patients regain partial adrenal function months to years after stopping mitotane. Others develop permanent adrenal insufficiency requiring lifelong hormone replacement. Regular cortisol testing after stopping mitotane helps determine if your adrenal glands are recovering or if you need continued replacement therapy.

Yes, you typically need to double or triple your hydrocortisone dose during illness, injury, or surgery. Physical stress increases cortisol demand, but your adrenal glands cannot respond normally during mitotane therapy. Your doctor will provide specific sick day instructions. Severe illness may require emergency injectable hydrocortisone and immediate medical attention.

Eating regular meals with adequate healthy fats helps maintain stable blood sugar and supports mitotane absorption. Staying well hydrated and eating enough salt helps manage blood pressure when cortisol is low. Avoid alcohol, as it can interfere with cortisol metabolism. Gentle exercise is beneficial, but avoid overexertion without adjusting your steroid doses first.

Your doctor may order additional tests to monitor treatment effects and overall health. These might include mitotane blood levels to ensure therapeutic dosing, thyroid function tests, electrolyte panels, liver function tests, and complete blood counts. Rite Aid's panel includes many of these markers along with cortisol, providing a broader view of your health during treatment.

Yes, timing matters because cortisol levels naturally fluctuate throughout the day. Morning cortisol tests, typically done between 7 and 9 AM, provide the most useful baseline information. If you take hydrocortisone replacement, your doctor may want you to delay your morning dose until after the blood draw. Always follow your doctor's specific instructions for test timing.

Monitoring continues for months to years after stopping mitotane to assess adrenal recovery. Most doctors recommend cortisol testing every 3 to 6 months initially, then annually if levels remain stable. Some patients need lifelong monitoring if they develop permanent adrenal insufficiency. Your oncologist and endocrinologist will determine your long-term monitoring schedule based on your recovery progress.